CONTENTS:
• The genetics of alcohol dependence: Advancing towards systems-based approaches. Palmer R.H.C., McGeary J.E., Francazio S., Raphael B.J., Lander A.D., Heath A.C., et al., p. 179-191.
• Quality of life among alcohol-dependent patients: How satisfactory are the available instruments? A systematic review. Luquiens A., Reynaud M., Falissard B., Aubin H.J., p. 192-202.
• Spending trends on substance abuse treatment under private employer-sponsored insurance, 2001–2009. Mark T.L., Vandivort-Warren R., p. 203-207.
• Trait impulsivity and prefrontal gray matter reductions in cocaine dependent individuals. Moreno-López L., Catena A., Fernández-Serrano M.J., Delgado-Rico E., Stamatakis E.A., Pérez-García M., et al., p. 208-214.
• A Stage I pilot study of acceptance and commitment therapy for methadone detoxification. Stotts A.L., Green C., Masuda A., Grabowski J., Wilson K., Northrup T.F., et al., p. 215-222.
• Sobriety as an admission criterion for transitional housing: A multi-site comparison of programs with a sobriety requirement to programs with no sobriety requirement. Tsai J., Rosenheck R.A., Kasprow W.J., McGuire J.F., p. 223-229.
• Gray-matter volume in methamphetamine dependence: Cigarette smoking and changes with abstinence from methamphetamine. Morales A.M., Lee B., Hellemann G., O’Neill J., London E.D., p. 230-238.
• Individual variability in the locus of prefrontal craving for nicotine: Implications for brain stimulation studies and treatments. Hanlon C.A., Jones E.M., Li X., Hartwell K.J., Brady K.T., George M.S., p. 239-243.
• Development and validation of the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) in adult cannabis users in treatment. Young R.M., Gullo M.J., Feeney G.F.X., Connor J.P., p. 244-251.
• Prefrontal and limbic resting state brain network functional connectivity differs between nicotine-dependent smokers and non-smoking controls. Janes A.C., Nickerson L.D., Frederick B.d., Kaufman M.J., p. 252-259.
• Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics. Tran B.X., Ohinmaa A., Duong A.T., Nguyen L.T., Vu P.X., Mills S., et al., p. 260-266.
• Marijuana use trajectories during the post-college transition: Health outcomes in young adulthood. Caldeira K.M., O’Grady K.E., Vincent K.B., Arria A.M., p. 267-275.
• Dose–response relationship between tobacco or alcohol consumption and the development of diabetes mellitus in Japanese male workers. Teratani T., Morimoto H., Sakata K., Oishi M., Tanaka K., Nakada S., et al., p. 276-282.
• Trajectories of criteria of nicotine dependence from adolescence to early adulthood. Hu M.-C., Griesler P.C., Schaffran C., Wall M.M., Kandel D.B., p. 283-289.
• All-cause mortality among individuals with disorders related to the use of methamphetamine: A comparative cohort study. Callaghan R.C., Cunningham J.K., Verdichevski M., Sykes J., Jaffer S.R., Kish S.J., p. 290-294.
• Transition to parenthood and substance use disorders: Findings from a 30-year longitudinal study. Fergusson D.M., Boden J.M., John Horwood L., p. 295-300.
• Stereotypic information about drinkers and students’ observed alcohol intake: An experimental study on prototype–behavior relations in males and females in a naturalistic drinking context. Teunissen H.A., Spijkerman R., Larsen H., Kremer K.A., Kuntsche E., Gibbons F.X., et al., p. 301-306.
• Adolescent exposure to nicotine results in reinforcement enhancement but does not affect adult responding in rats. Weaver M.T., Geier C.F., Levin M.E., Caggiula A.R., Sved A.F., Donny E.C., p. 307-312.
• Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. Karschner E.L., Schwope D.M., Schwilke E.W., Goodwin R.S., Kelly D.L., Gorelick D.A., et al., p. 313-319.